The impact of COVID-19 pandemic on fragility hip fracture management and mortality rate

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20221028002

Enrollment

859

Registered

2022-10-28

Start date

2019-05-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mortality rate in osteoporotic hip fracture between COVID-19 pandemic and pre-pandemic period Fragility hip fracture, osteoporotic fracture, COVID-19, mortality

Interventions

Osteoporotic hip fractures admissions between May 2019 and March 2020 ,Osteoporotic hip fractures admissions between April 2020 to February 2021

Treatment,Treatment

Pre-COVID-19 pandemic,COVID-19 pandemic

Eligibility

Sex/Gender

All

Age

50 Years to No maximum

Inclusion criteria

Inclusion criteria: Hip fracture from low energy trauma

Exclusion criteria

Exclusion criteria: Pathological fracture Fail to adhere follow-up plan

Design outcomes

Primary

Measure	Time frame
Mortality rate and 1-year mortality rate from admission to 12 months after discharge Dead cases divided by total cases	—

Secondary

Measure	Time frame
Serum vitamin D level During admission Serum vitamin D level from blood test	—

Countries

Thailand

Contacts

Public ContactTana Rattanakitkoson

Maharat Nakhon Ratchasima Hospital

kyo_bank@hotmail.com0897264859

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026